These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15459249)

  • 1. Farnesylthiosalicylic acid inhibits mammalian target of rapamycin (mTOR) activity both in cells and in vitro by promoting dissociation of the mTOR-raptor complex.
    McMahon LP; Yue W; Santen RJ; Lawrence JC
    Mol Endocrinol; 2005 Jan; 19(1):175-83. PubMed ID: 15459249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
    Yue W; Wang J; Li Y; Fan P; Santen RJ
    Int J Cancer; 2005 Dec; 117(5):746-54. PubMed ID: 15957161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor.
    Choi KM; McMahon LP; Lawrence JC
    J Biol Chem; 2003 May; 278(22):19667-73. PubMed ID: 12665511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes.
    Kudchodkar SB; Yu Y; Maguire TG; Alwine JC
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14182-7. PubMed ID: 16959881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation.
    Carrière A; Cargnello M; Julien LA; Gao H; Bonneil E; Thibault P; Roux PP
    Curr Biol; 2008 Sep; 18(17):1269-77. PubMed ID: 18722121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR phosphorylated at S2448 binds to raptor and rictor.
    Rosner M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2010 Jan; 38(1):223-8. PubMed ID: 19145465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.
    Hara K; Maruki Y; Long X; Yoshino K; Oshiro N; Hidayat S; Tokunaga C; Avruch J; Yonezawa K
    Cell; 2002 Jul; 110(2):177-89. PubMed ID: 12150926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.
    Oshiro N; Yoshino K; Hidayat S; Tokunaga C; Hara K; Eguchi S; Avruch J; Yonezawa K
    Genes Cells; 2004 Apr; 9(4):359-66. PubMed ID: 15066126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.
    Kim DH; Sarbassov DD; Ali SM; Latek RR; Guntur KV; Erdjument-Bromage H; Tempst P; Sabatini DM
    Mol Cell; 2003 Apr; 11(4):895-904. PubMed ID: 12718876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.
    Sarbassov DD; Ali SM; Kim DH; Guertin DA; Latek RR; Erdjument-Bromage H; Tempst P; Sabatini DM
    Curr Biol; 2004 Jul; 14(14):1296-302. PubMed ID: 15268862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raptor, a binding partner of target of rapamycin.
    Yonezawa K; Tokunaga C; Oshiro N; Yoshino K
    Biochem Biophys Res Commun; 2004 Jan; 313(2):437-41. PubMed ID: 14684181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction.
    Hong-Brown LQ; Brown CR; Kazi AA; Huber DS; Pruznak AM; Lang CH
    J Cell Biochem; 2010 Apr; 109(6):1172-84. PubMed ID: 20127721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1.
    Wang L; Rhodes CJ; Lawrence JC
    J Biol Chem; 2006 Aug; 281(34):24293-303. PubMed ID: 16798736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.
    Kim DH; Sarbassov DD; Ali SM; King JE; Latek RR; Erdjument-Bromage H; Tempst P; Sabatini DM
    Cell; 2002 Jul; 110(2):163-75. PubMed ID: 12150925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
    Vander Haar E; Lee SI; Bandhakavi S; Griffin TJ; Kim DH
    Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
    Guan Y; Zhang Y; Xiao L; Li J; Wang JP; Chordia MD; Liu ZQ; Chung LW; Yue W; Pan D
    Mol Pharm; 2017 Jan; 14(1):1-13. PubMed ID: 26992462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size.
    Eguchi S; Tokunaga C; Hidayat S; Oshiro N; Yoshino K; Kikkawa U; Yonezawa K
    Genes Cells; 2006 Jul; 11(7):757-66. PubMed ID: 16824195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state kinetic and inhibition studies of the mammalian target of rapamycin (mTOR) kinase domain and mTOR complexes.
    Tao Z; Barker J; Shi SD; Gehring M; Sun S
    Biochemistry; 2010 Oct; 49(39):8488-98. PubMed ID: 20804212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.